Literature DB >> 14579395

Magnetic resonance image-guided proteomics of human glioblastoma multiforme.

Susan K Hobbs1, Gongyi Shi, Ron Homer, Griff Harsh, Scott W Atlas, Mark D Bednarski.   

Abstract

PURPOSE: To investigate the correlation between gadolinium contrast-enhancement patterns on T1-weighted magnetic resonance (MR) images and spatial changes in protein expression profiles in human glioblastoma multiforme (GBM) and the use of imaging as a noninvasive technique to evaluate the heterogeneity of solid tumors prior to microarray analysis.
MATERIALS AND METHODS: Four patients with MR images and confirmed diagnosis of GBM were enrolled in the study. Intraoperative stereotaxy was used in conjunction with MR images to identify contrast-enhanced (CE) and nonenhanced (NE) regions of the tumor during surgical resection. Total protein was extracted from resected tumor samples using standard techniques and subjected to proteomic analysis using surface enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS).
RESULTS: We found that protein profiles from CE and NE regions within a given tumor have qualitative and semiquantitative proteomic pattern differences, suggesting an altered gene expression profile that correlates with detectable tissue imaging parameters. We also found that CE regions within the same tumor exhibited distinct differences in protein expression profiles, despite similar histological features. In addition, there were marked similarities in the proteomic patterns among the NE regions across all patients, while the CE regions were distinct, suggesting that the CE regions have complex protein profiles unique to individuals.
CONCLUSION: The results demonstrate that major differences in protein expression patterns within a tumor can be correlated to radiographic findings. Image-guided proteomics holds promise for characterizing tissue prior to microarray analysis designed to identify specific diagnostic markers and therapeutic targets within solid tumors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579395     DOI: 10.1002/jmri.10395

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  46 in total

1.  Amide proton transfer imaging of the human brain.

Authors:  Jinyuan Zhou
Journal:  Methods Mol Biol       Date:  2011

2.  Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.

Authors:  Shanshan Jiang; Tianyu Zou; Charles G Eberhart; Maria A V Villalobos; Hye-Young Heo; Yi Zhang; Yu Wang; Xianlong Wang; Hao Yu; Yongxing Du; Peter C M van Zijl; Zhibo Wen; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-07-16       Impact factor: 4.668

3.  Preliminary study on proteomics of gastric carcinoma and its clinical significance.

Authors:  Hong-Gang Qian; Jing Shen; Hong Ma; Hua-Chong Ma; Ya-Hui Su; Chun-Yi Hao; Bao-Cai Xing; Xin-Fu Huang; Cheng-Chao Shou
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 4.  Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics.

Authors:  Benjamin M Ellingson
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

5.  Molecular Imaging Using Endogenous Cellular Proteins.

Authors:  Zhou Jinyuan; Hong Xiaohua
Journal:  Bo Pu Xue Za Zhi       Date:  2013

6.  Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging.

Authors:  Jinyuan Zhou; Jaishri O Blakeley; Jun Hua; Mina Kim; John Laterra; Martin G Pomper; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

7.  Multifarious proteomic signatures and regional heterogeneity in glioblastomas.

Authors:  Chul-Kee Park; Ji Hye Jung; Sung-Hye Park; Hee-Won Jung; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2009-02-15       Impact factor: 4.130

8.  Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.

Authors:  Jinyuan Zhou; He Zhu; Michael Lim; Lindsay Blair; Alfredo Quinones-Hinojosa; Steven A Messina; Charles G Eberhart; Martin G Pomper; John Laterra; Peter B Barker; Peter C M van Zijl; Jaishri O Blakeley
Journal:  J Magn Reson Imaging       Date:  2013-02-25       Impact factor: 4.813

9.  Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.

Authors:  Rachel W Chan; Hanbo Chen; Sten Myrehaug; Eshetu G Atenafu; Greg J Stanisz; James Stewart; Pejman Jabehdar Maralani; Aimee K M Chan; Shadi Daghighi; Mark Ruschin; Sunit Das; James Perry; Gregory J Czarnota; Arjun Sahgal; Angus Z Lau
Journal:  J Neurooncol       Date:  2020-11-16       Impact factor: 4.130

10.  Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model.

Authors:  Xiaohua Hong; Li Liu; Meiyun Wang; Kai Ding; Ying Fan; Bo Ma; Bachchu Lal; Betty Tyler; Antonella Mangraviti; Silun Wang; John Wong; John Laterra; Jinyuan Zhou
Journal:  Neuro Oncol       Date:  2013-12-22       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.